| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |